drugset / Trial / NCT01224327

Umbilical Cord Mesenchymal Stem Cells Infusion Via Hepatic Artery in Cirrhosis Patients

NCT01224327

Phase 1/2 Unknown 50 enrolled Qingdao University
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the efficacy of umbilical cord mesenchymal stem cells (MSCs) infusion via hepatic artery in the treatment of liver cirrhosis.

Timeline

Start
2010-10
Primary completion
2012-10
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject mesenchymal stem cells Cell therapy Other

Indications